Imdex Limited provided earnings guidance for the fiscal year 2019. The company provided that investment in R&D during fiscal year 2019 is expected to be at similar levels to fiscal year 2018. At the same time, organic focus is yet to deliver increases in EBITDA during fiscal year 2019. The company provided that tax expense will normalize to 30% in the fiscal year 2019. The company provided that organic growth expected in the fiscal year 2019. The company announced that $18.2 million was invested in new plant and equipment, $2 million of which was drawn from inventory. The company expects similar levels in fiscal year 2019 as demand for new technologies continue to grow.